COVID-19 Impact on Community Oncology Practices
and Implications for Life Sciences Companies
Wednesday, May 6 | 3:00pm - 4:00pm EDT

Please join Dr. Marcus Neubauer, Chief Medical Officer, The US Oncology Network and Sarah Alwardt, VP Operations, Real World Evidence and Commercial Intelligence at McKesson, as they discuss the impact of the COVID-19 crisis on community oncology practices and the implications for life sciences companies.

They will explore how it is affecting patient access and clinical decisions related to cancer treatment; how life sciences companies can support community oncology during this pandemic; questions which life sciences companies are wrestling with, including the impact on new and existing clinical trials; and what we can learn from the early insights found in McKesson’s iKnowMed oncology EHR data.


Marcus Neubauer, MD, Chief Medical Officer, The US Oncology Network

Dr. Marcus Neubauer is the Chief Medical Officer for The US Oncology Network. Dr. Neubauer was a practicing medical oncologist for over 20 years as a physician and leader within a Network practice. Prior to serving as The Network CMO,  he was the vice president and medical director for payer, clinical services, and value-based care, working with over 1,400 community oncologists across the country. He is a recognized leader in innovation in clinical pathways, value-based care and contracting and the Center for Medicare and Medicaid Innovation’s (CMMI®) Oncology Care Model.

Sarah Alwardt, PhD, Vice President of Operations, Commercial Intelligence and Real World Evidence at McKesson

Sarah Alwardt, PhD. is Vice President of Operations for Data, Evidence & Insights at McKesson and leads the real-world evidence and commercial intelligence operational teams. She is an accomplished author, speaker and leader with 15+ years of domestic and international experience in delivering data-driven insights for pharmaceutical companies. Prior to joining McKesson, Dr. Alwardt spent 10 years at Humana where she revitalized the research business and drove strategic planning for Humana Pharmacy Solutions.

Sponsored by:

Amplifying the HEOR Impact through Medical Collaboration
and Digital Transformation

Thursday, April 23, 10:00am - 11:00am EDT

From Pipeline to Value | Real-World Data for Immunologic Disorders
Thursday, April 30, 11:00am - 12:00pm EDT

Communicating and Implementing Real-World Evidence
Thursday, May 21, 12:00pm - 1:00pm EST


Faster to Market:
Transforming HEOR & RWE Using Virtual Sourcing

April 15, 2020

Rise of the Robots 2.0:
Real Talk About Artificial Intelligence In Systematic Reviews

February 25, 2020

Click here to view more webinars.

In the past you have provided HealthEconomics.Com with your email address. Occasionally you will receive brief announcements on products, services, news and jobs from HealthEconomics.Com or our Partners.

If you don't wish to receive these announcements, you may immediately unsubscribe from this list here, or send your request in writing to HealthEconomics.Com, 1327 Walnut, Jacksonville, FL, 32206. Read more about our privacy policy here. You may also request a copy in writing using the address above.

To ensure you continue to receive emails from HealthEconomics.Com, please click here.

Registration does not guarantee acceptance to attend this webinar. All registration will be reviewed by sponsor within 48 hours of receipt. HealthEconomics.Com does not approve or deny any registrations. This responsibility is held solely by the sponsor..